FL
Foley & Lardner
More
Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors that contribute to exceptional human longevity and healthy aging.
United States
Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
Article Insights
Foley & Lardner are most popular:
within Criminal Law, Government, Public Sector and Insurance topic(s)
The Long Life Family Study (LLFS) is a multi-decade, multicenter
research program designed to uncover the genetic and biological
factors that contribute to exceptional human longevity and healthy
aging. First launched in the mid-2000s, LLFS recruited nearly 5,000
individuals from 539 families across the U.S. and Denmark —
families enriched for long life spans — spanning three
generations, with the oldest members averaging around 90 years at
recruitment.
Previously, the project received $68 million over five years in
2019 from the National Institutes of Health (NIH) National
Institute on Aging, with Washington University in St. Louis leading
as the coordinating and analysis center alongside partner field
sites at Boston University, Columbia University, the University of
Pittsburgh, and the University of Southern Denmark. Recently, NIH
extended funding with an additional $80 million over five years,
allowing LLFS to operate through 2030. To date, more than 5,400
individuals have been enrolled and followed through repeated
in-home assessments over nearly 20 years.
The current phase incorporates cutting-edge
“long-read” whole-genome sequencing with PacBio
technology (up to 7,800 samples), epigenomics, proteomics,
metabolomics, and microbiome analysis, enabling detection of rare
protective variants, methylation patterns, and other biological
markers that standard approaches often miss.
Impact for Precision Medicine
LLFS’s search for rare, protective genetic variants and the
integration of multi-omics with detailed phenotypic and
longitudinal data align closely with precision health goals, using
genetic signatures to predict disease resistance, tailor preventive
strategies, and develop therapies targeted to individual biological
profiles. The study’s cross-generational design also helps
identify life-course and environmental factors that may modify
genetic risk or resilience.
In an era of overall tightening federal research budgets, this
sustained and expanded NIH investment underscores the perceived
high impact of LLFS. The findings could directly inform
personalized aging interventions, biomarker development, and
therapies aimed at extending both lifespan and health span. The
scale and longitudinal depth of LLFS will undoubtedly impact
geriatrics, chronic disease prevention, and public health
policy.
References:
Family Longevity Study
Wins $80M in NIH Funding, Will Sequence up to 7.8K Participants
With PacBio
Washington
University-Led Team Wins Five-Year, $68M NIH Grant for Longevity
Sequencing Study
NIH Awards $68m
to Washington University St. Louis for Health Longevity
Study
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.